FDA Clears New Drug Application for an Experimental Triple Action Cystic Fibrosis Drug
Pexels / Pixabay

FDA Clears New Drug Application for an Experimental Triple Action Cystic Fibrosis Drug

According to a story from Market Watch, the biotechnology company Vertex Pharmaceuticals, Inc. has announced recently that the US Food and Drug Administration (FDA) has accepted the company's New Drug…

Continue Reading FDA Clears New Drug Application for an Experimental Triple Action Cystic Fibrosis Drug

The Impact of Patient Registries on Research and How You Can Join

  A recent article published in Curetoday highlights not only the many new and successful therapies available to cancer patients but it also illustrates how patients can connect to other…

Continue Reading The Impact of Patient Registries on Research and How You Can Join
Close Menu